Chenggong Wang

Chenggong Wang

Auto-generated profile, based on publicly available information

Chenggong Wang

National Clinical Research Center of Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 January 2022 in Advances in Civil Engineering
Verified
Journal Article
Open access
PDF file
CWChenggong Wang
Chenggong Wang
DCDiankai Cao
Diankai Cao
XLXiaoyang Liu
Xiaoyang Liu
YJYucai Jing
Yucai Jing
WLWenzhuo Liu
Wenzhuo Liu
GYGuotao Yang
Guotao Yang
Bolted shear connectors have the advantages of being easily fitted and dismantled during construction, the initial elastic stiffness of which has a great influence on the structural performance of the connected composite structures. In this paper, the initial elastic behaviors of three types of bolted shear connectors used in steel‐concrete composite structures (i.e., the bolt with nonembedded nut, the bolt with single‐embedded nut, and the bolt with double‐embedded nuts) are investigated using finite element analysis (FEA). After the FE models are verified against the experimental results in other literature, an extensive parametric study is carried out to investigate the effects of eight parameters of the composite structures on the initial shear stiffness and tension stiffness as well as coupling stiffness. Empirical formulas are subsequently developed for obtaining the initial elastic stiffness of the bolted shear connectors, based on which further FEA is performed. The FEA results are in good agreement with the experimental results, illustrating the effectiveness of the empirical formulas.

12 December 2025 in Medicine
Verified
Journal Article
Open access
XLXi Li
Xi Li
DZDa Zhong
Da Zhong
ZYZhen Yin
Zhen Yin
HLHua Liu
Hua Liu
WXWen-qing Xie
Wen-qing Xie
CWChenggong Wang
Chenggong Wang
Vascular Intestinal Disorder (VID) significantly impacts the global disease burden, with notable regional variations in incidence, prevalence, and Disability-Adjusted Life-Years (DALYs). While high-income countries have seen a decline in VID burden due to improved healthcare, lower-income regions continue to face rising VID rates. Understanding these trends is essential for developing effective health policies and interventions. This study aimed to analyze the global trends in VID incidence, prevalence, and DALYs from 1990 to 2021. We utilized data from the global burden of disease study to calculate age-standardized rates for incidence, prevalence, and DALYs of VID from 1990 to 2021. Joinpoint regression analysis was performed to assess trend changes over time. An age-period-cohort analysis explored the impact of age, period, and birth cohort on VID burden. Decomposition, inequality, and frontier analyses were conducted to investigate the contributions of aging, population growth, and epidemiological changes to the VID burden. Overall, the global trends of VID incidence, prevalence, and DALYs showed a decline over the past 3 decades. However, regional disparities were evident. High and upper-middle socio-demographic index (SDI) regions saw significant declines in both incidence and prevalence, while low and lower-middle SDI regions experienced increases. DALYs showed a decreasing trend in most regions, though certain areas, including Central Asia and Eastern Europe, demonstrated increases. The age-period-cohort analysis revealed that age is a significant determinant of VID burden, with incidence, prevalence, and DALYs increasing with age. Population growth and aging were found to be the main drivers of increased VID burden, while epidemiological changes contributed to a global reduction in VID burden. Inequality analysis showed persistent disparities, with low-SDI regions bearing a disproportionate share of the VID burden. Policymakers must focus on addressing health inequalities and ensuring equitable distribution of global health interventions. Future research should investigate the specific causes and subtypes of VID, and improve global health data monitoring to better predict and manage shifts in disease burden.

7 August 2026 in Measurement Science and Technology
Verified
Journal Article
Closed access
PDF file
YDYuqing Duan
Yuqing Duan
CWChenggong Wang
Chenggong Wang
XZXuanhao Zhang
Xuanhao Zhang
GYGuotao Yang
Guotao Yang
The health condition of road transportation infrastructure is directly related to driving safety and transportation efficiency. However, existing automated detection technologies still struggle to meet the requirements of large-scale, high-precision, and real-time inspection when confronted with challenges such as significant scale variation of damage targets, strong background texture interference, and fine cracks. This paper proposes a road defect detection model comprising C2f_PBA, CARAFE, and WPIoU, based on the you only look once version 8 (PCW-YOLO). The C2f_PBA module was designed and applied to the backbone network, employing a multi-branch parallel attention mechanism to extract features at different scales. This effectively enhances the model’s ability to capture heterogeneous damage. In the neck network, a CARAFE content-aware upsampling operator is introduced to replace conventional nearest-neighbor interpolation, enabling precise recovery of semantic details and edge information in feature maps via an adaptive kernel prediction mechanism, thereby addressing feature distortion during upsampling. In addition, a variant of wise intersection over union based on minimum point distance intersection over union is proposed WPIoU. The WPIoU loss function combines geometric constraints with a dynamic focusing mechanism to optimize the bounding box regression process, significantly improving the localization accuracy for targets with extreme aspect ratios and low-quality samples. Evaluations using the RDD2022 dataset demonstrate that the PCW-YOLO framework outperforms the traditional YOLOv8 architecture, achieving improvements of 2.1%, 1.1%, and 2.2% in precision, recall, and mAP, respectively. To verify the model’s generalization capabilities, subsequent evaluations were conducted using the SVRDD dataset. The results showed that the optimized network achieved a 5.2% increase in precision, a 1.4% increase in recall, and a 3.8% increase in mAP, thereby providing a more precise and efficient solution for road defect detection.

13 February 2026 in Medicine
Verified
Journal Article
Open access
XLXi Li
Xi Li
DZDa Zhong
Da Zhong
ZYZhen Yin
Zhen Yin
HLHua Liu
Hua Liu
WXWen-qing Xie
Wen-qing Xie
CWChenggong Wang
Chenggong Wang
Background: Previous meta-analyses have extensively compared the outcomes of intravascular imaging-guided versus coronary angiography-guided percutaneous coronary intervention (PCI) in the treatment of coronary artery disease. However, conducting repeated meta-analyses within a short period may increase the probability of type I or type II errors. Therefore, we employed both traditional meta-analysis and trial sequential analysis (TSA) methods to compare the clinical outcomes of intravascular imaging-guided and coronary angiography-guided PCI. Methods: We searched PubMed, Cochrane Library, Embase, and Web of Science for literature comparing intravascular imaging-guided versus coronary angiography-guided PCI from inception to August 10, 2024. Four researchers, divided into 2 groups, independently extracted the data. The primary outcomes were major adverse cardiovascular events (MACEs) and target lesion failure (TLF). Secondary outcomes included stent thrombosis and all-cause mortality. TSA was used to analyze these outcomes. Results: A total of 23 randomized controlled trials with 17,766 participants were included. Compared to angiography, intravascular ultrasound has a significant advantage in reducing MACE (risk ratio [RR]: 0.66; 95% confidence interval [CI]: 0.55–0.80) and TLF (RR: 0.64; 95% CI: 0.54–0.75) during follow-up, supported by high certainty of evidence and confirmed by an 80% power TSA, demonstrating a true positive effect. However, no significant differences were observed in reducing stent thrombosis or all-cause mortality. Similarly, compared to angiography, optical coherence tomography shows a significant advantage in reducing MACE beyond 1 year (RR: 0.79; 95% CI: 0.64–0.99), but further exploration is needed, given that only 3 studies were included. In other aspects, including the reduction of stent thrombosis and all-cause mortality, no significant differences were found. Conclusion: Intravascular ultrasound showed truly superior efficacy in reducing MACE and TLF compared to angiography. However, additional studies are needed to further assess the effectiveness of optical coherence tomography.